A multi-institutional assessment of low-dose protocols in chest computed tomography: Dose and image quality.

Background: Low-dose CT (LDCT) chest protocols have widespread clinical applications for many indications; as a result, there is a need for protocol assessment prior to standardization. Dalhousie University and Oslo Metropolitan University have a formally established cooperative relationship. Purpose: The purpose is to assess radiation dose and image quality for LDCT chest protocols in seven different hospital locations in Norway and Canada. Material and methods: Retrospective dosimetry data, volumetric CT dose index (CTDIvol), and dose length product (DLP) from 240 average-sized patients as well as CT protocol parameters were included in the survey. Effective dose (ED) and size-specific dose estimate (SSDE) were calculated for each examination. For a quantitative image quality analysis, noise, CT number, and signal-to-noise ratio (SNR) were determined for three regions in the chest. The contrast-to-noise ratio (CNR) was calculated for lung parenchyma in comparison to the subcutaneous fat. Differences in dose and image quality were evaluated by a single-factor ANOVA test. A two-sample t-test was performed to determine differences in means between individual scanners. Results: The ANOVA test revealed significant differences (p < .05) in dose values for all scanners, including identical scanner models. Statistically significant differences (p < .05) were determined in mean values of the SNR distributions between the scanners in all three measured regions in the chest, as well as the CNR values. Conclusion: The observed variations in dose and image quality measurements, even within the same hospitals and between identical scanner models, indicate a potential for protocol optimization in the involved hospitals in both countries.

SURVEY OF COMPUTED TOMOGRAPHY PRACTICE IN UKRAINE AND ESTABLISHMENT OF NATIONAL DIAGNOSTIC REFERENCE LEVELS FOR MOST COMMON CT EXAMINATIONS OF ADULTS.

This study reports results of the first nationwide survey of computed tomography (CT) practice in Ukraine and proposed national diagnostic reference levels (DRLs) for common CT examinations. The collected data included characteristics of CT scanners, frequency of CT exams per anatomical region, dose indices CTDIvol and dose-length product (DLP). National DRLs were proposed at the 75th percentile of median dose indices distributions for four common CT protocols: head without contrast (brain examinations for stroke and trauma), routine chest without contrast, single-phase contrast-enhanced CT of abdomen and pelvis and oncology protocol (chest-abdomen-pelvis). The results showed 4- to 9-fold variations of median dose indices between CT scanners for the same type of examination. The following values of the CTDIvol and DLP were proposed as national DRLs: 59 mGy and 1130 mGy•cm for head, 14 mGy and 492 mGy•cm for chest, 22 mGy and 845 mGy•cm for abdomen/pelvis and 2120 mGy•cm for oncological protocol.

A survey of local diagnostic reference levels for the head, thorax, abdomen and pelvis computed tomography in Norway and Canada.

Background: Computed tomography (CT) contributes to 60% of the collective dose in medical imaging. Literature has demonstrated that patient dose varies across regions and countries. Establishing diagnostic reference levels (DRLs) contributes to the optimization of clinical practices and radiation protection. Purpose: To survey the dose indices (CTDIvol and dose-length product) for frequently performed CT examinations from the chosen hospitals in Norway and Canada and to determine local DRLs (LDRLs) based on the collected data. Material and Methods: The survey included eight scanners from two Norwegian hospitals and four scanners from four Canadian hospitals. Dosimetry data were collected for the following routine CT examinations: head, contrast-enhanced thorax, and abdomen and pelvis. Overall 480 adult average-sized patients from Norway and 360 from Canada were included in the survey. The LDRLs were determined as the 75th percentile of distributions of median values of dose indicators from different CT scanners. The differences in dose between scanners were determined using single-factor ANOVA. Results: The LDRLs determined in Norway were higher overall than in Canada. The obtained values were compared to the national DRLs. The dose from several scanners in Norway exceeded national Norwegian DRLs, while Canadian LDRLs were below the Canadian reference levels. The differences between the means of the dose distributions from each scanner were statistically significant (p < 0.05) for all examinations with exception of identical scanners located in the same hospital and using the same protocols. Conclusion: Observed dose variations even in the same hospital, or from the same scanner model confirmed the need for CT protocol optimization.

Diagnostic performance and radiation dose of reduced vs. standard scan range abdominopelvic CT for evaluation of appendicitis.

OBJECTIVE: To compare the diagnostic performance and radiation dose of reduced vs. standard scan range CT in diagnosing appendicitis. METHODS: We retrospectively evaluated 531 consecutive adults who underwent emergency contrast-enhanced CT for abdominal pain or suspected appendicitis between July 2018 and March 2019. One hundred eighty-one young adults (mean age, 26 ± 6 years) were imaged from L2 to the symphysis pubis (reduced protocol). A total of 350 older patients (mean age, 55 ± 17 years) and those with a wider differential diagnosis were imaged from the diaphragm to the ischium (standard protocol). The reference standard was histopathology (surgical cases) or 3 months of medical record follow-up (nonsurgical cases). Sensitivity, specificity, and accuracy were calculated. Mean dose-length products (DLP) were compared (t-test). Using an anthropomorphic phantom, organ doses were measured on CT scanners with (scanner 1) and without (scanner 2) automatic voltage selection; effective radiation doses were calculated. RESULTS: The frequency of appendicitis was 57/181 (31.5%) and 80/350 (22.9%) in the reduced and standard groups, respectively. Results of the reduced and standard protocols respectively were as follows (95% CI in parentheses): sensitivity, 98.2% (90.4-99.9%) and 100.0 (95.3-100.0%); specificity, 99.2% (95.6-100.0%) and 99.6% (97.9-100.0%); accuracy, 97.8% and 97.4%; mean DLPs, 363 ± 191mGy∙cm and 633 ± 591mGy∙cm (p < 0.0001). Phantom-based measurements of effective dose were 47% lower on scanner 1 (4.64 vs. 2.48 mSv) and 26% lower on scanner 2 (4.68 vs. 3.45 mSv) with the reduced protocol. CONCLUSION: For young adults with clinically suspected appendicitis, a reduced scan range CT protocol is as sensitive, specific, and accurate as a standard scan range CT and imparts significantly less radiation dose. KEY POINTS: • A reduced scan range CT protocol in young adults with high suspicion of appendicitis demonstrates similar diagnostic performance as a full-range abdominopelvic CT in undifferentiated adult patients. • The reduced scan range CT protocol imparts significantly less radiation dose: 57% based on dose-length product data and 26-47% based on anthropomorphic phantom data.

COMP Report: A survey of radiation safety regulations for medical imaging x-ray equipment in Canada.

X-ray regulations and room design methodology vary widely across Canada. The Canadian Organization of Medical Physicists (COMP) conducted a survey in 2016/2017 to provide a useful snapshot of existing variations in rules and methodologies for human patient medical imaging facilities. Some jurisdictions no longer have radiation safety regulatory requirements and COMP is concerned that lack of regulatory oversight might erode safe practices. Harmonized standards will facilitate oversight that will ensure continued attention is given to public safety and to control workplace exposure. COMP encourages all Canadian jurisdictions to adopt the dose limits and constraints outlined in Health Canada Safety Code 35 with the codicil that the design standards be updated to those outlined in NCRP 147 and BIR 2012.

DOES THE USE OF CONTEMPORARY CT SCANNERS ALTER THE RADIATION DOSE DEBATE IN THE IMAGING WORK UP FOR PULMONARY EMBOLISM?

The aim of this study was to compare patient doses from ventilation perfusion single photon emission computed tomography (V/Q SPECT) and computed tomography pulmonary angiography (CTPA) performed on contemporary scanners. Effective dose (ED) for V/Q SPECT was calculated using organ doses per unit administered activity of the radiopharmaceuticals. Organ doses in CT were measured using nanoDot aluminium oxide optically stimulated dosemeters placed within a female adult anthropomorphic phantom. To simulate a larger patient, the phantom was wrapped in three layers of Superflab sheets. The V/Q SPECT resulted in ED of 2.82 mSv and a breast dose of 1.12 mGy. The CTPA dose was 1.82 ± 0.42 and 3.43 ± 0.91 mSv, whilst dose to the breast tissue was 2.86 ± 0.86 and 5.95 ± 0.44 mGy for small- and medium-sized patients, respectively.

Diagnostic Reference Levels and Monitoring Practice Can Help Reduce Patient Dose From CT Examinations.

OBJECTIVE: The purpose of this study is to establish provincial diagnostic reference levels (DRLs) and to determine whether this process may help reduce the patient radiation dose from the most frequently performed CT examinations. MATERIALS AND METHODS: We investigated the following CT examinations: head, chest, low-dose chest, abdomen and pelvis, and chest, abdomen, and pelvis examinations. The sample for each protocol included 15 patients of average body weight (mean [± SD], 70 ± 20 kg). The differences in dose between scanners were evaluated using one-way ANOVA. Correlations between dose, scanner age, and the number of detector rows were assessed using the Pearson correlation coefficient. A sample of abdominal and chest examinations were randomized and blinded for review by experienced radiologists who graded diagnostic image quality. Provincial DRLs were calculated as the 75th percentile of patient dose distributions. For hospitals with doses exceeding the DRLs, dose reduction was recommended, followed by another survey. RESULTS: The initial survey included data of 1185 patients, and an additional 180 patients were surveyed after protocol optimization. The differences between the mean values of the dose distributions from each scanner were statistically significant (p < 0.05) for all examinations. The variation was greatest for low-dose chest CT, with a greater than fivefold difference in the mean dose values noted between scanners. A very weak correlation was found between dose and scanner age or the number of detector rows. Analysis of image quality revealed no statistically significant differences in any scoring categories, with the exception of the noise category in abdominal imaging. Implementation of the DRLs allowed a reduction in patient dose of up to 41% as a result of a protocol change. CONCLUSION: Establishing provincial DRLs allows an effective reduction in patient dose without resulting in degradation of image quality.

ASSESSMENT OF EFFECTIVE DOSE FROM CONE BEAM CT IMAGING IN SPECT/CT EXAMINATION IN COMPARISON WITH OTHER MODALITIES.

The aim of this study was to assess radiation dose from the cone beam computed tomography (CBCT) component of single photon emission tomography/computed tomography (SPECT/CT) examinations and to compare it with the radiopharmaceutical related dose as well as dose from multidetector computed tomography (MDCT). Effective dose (ED) from computed tomography (CT) was estimated using dose-length product values and anatomy-specific conversion factors. The contribution from the SPECT component was evaluated using ED per unit administered activity for the radiopharmaceuticals listed in the International Commission on Radiological Protection Publications 80 and 106. With the exception of cardiac studies (0.11 mSv), the CBCT dose (3.96-6.04 mSv) was similar to that from the radiopharmaceutical accounting for 29-56 % of the total ED from the examination. In comparison with MDCT examinations, the CBCT dose was 48 and 42 % lower for abdomen/pelvis and chest/abdomen/pelvis scans, respectively, while in the chest the CBCT scan resulted in higher dose (23 %). Radiation dose from the CT component should be taken into consideration when evaluating total SPECT/CT patient dose.

Stimulation of apoptotic pathways in liver cancer cells: An alternative perspective on the biocompatibility and the utility of biomedical glasses.

A host of research opportunities with innumerable clinical applications are open to biomedical glasses if one considers their potential as therapeutic inorganic ion delivery systems. Generally, applications have been limited to repair and regeneration of hard tissues while compositions are largely constrained to the original bioactive glass developed in the 1960s. However, in oncology applications the therapeutic paradigm shifts from repair to targeted destruction. With this in mind, the composition-structure-property-function relationships of vanadium-containing zinc-silicate glasses (0.51SiO2-0.29Na2O-(0.20-X)ZnO-XV2O5, 0 ≤ X ≤ 0.09) were characterized in order to determine their potential as therapeutic inorganic ion delivery systems. Increased V2O5mole fraction resulted in a linear decrease in density and glass transition temperature (Tg).(29)Si MAS NMR peak maxima shifted upfield while(51)V MAS NMR peak maxima were independent of V2O5content and overlapped well with the spectra NaVO3 Increased V2O5mole fraction caused ion release to increase. When human liver cancer cells, HepG2, were exposed to these ions they demonstrated a concentration-dependent cytotoxic response, mediated by apoptosis. This work demonstrates that the zinc-silicate system studied herein is capable of delivering therapeutic inorganic ions at concentrations that induce apoptotic cell death and provide a simple means to control therapeutic inorganic ion delivery.

Radiation Dose from 3D Rotational vs. Conventional 2D Digital Subtraction Angiography in Intracranial Aneurysm Coiling.

PURPOSE: To compare patient effective dose resulting from two alternative imaging protocols for pre-coiling assessment of intracranial aneurysms: a series of 2D Digital Subtraction Angiography (DSA) projections, and a 3D rotational angiography (RA) acquisition. METHODS: In a retrospective analysis, we investigated 44 patients who underwent endovascular coiling in our institution. Images were acquired on a biplane Image Intensifier system not equipped with dose-area product (DAP) meter. Conventional 2D DSA images were simulated with an anthropomorphic skull phantom. Entrance skin dose was measured with a 60 cc ion chamber, and the PCXMC Monte Carlo based software was used to calculate patient effective dose. For the RA protocol, a 16 cm computed tomography (CT) dosimetry phantom and a 100 mm pencil ion chamber were employed to measure the CT dose index. Patient effective dose was calculated with the ImPACT calculator. An unpaired two-tailed t-test was used to determine the significance of differences between patient doses in each group. RESULTS: Sixteen patients underwent the 2D DSA protocol with multiple projections; their mean number of cine runs was 5.1; the mean effective dose was 2.11 millisievert (mSv) (range 1.69-3.43 mSv). Twenty eight patients were assessed using the 3D RA protocol with the effective dose of 1.29 mSv. The difference between the means of two dose distributions was statistically significant (p=0.00028). CONCLUSION: Our study demonstrated that the patient effective dose was significantly lower from the 3D RA protocol than that from the 2D DSA protocol used in the planning of coiling of intracranial aneurysm.

Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization.

The purpose of this study was to synthesize and optimize intrinsically radiopaque composite embolic microspheres for sustained release of doxorubicin in drug-eluting bead transarterial chemoembolization. Using a design of experiments approach, 12 radiopaque composites composed of polylactic-co-glycolic acid and a radiopaque glass (ORP5) were screened over a range of compositions and examined for radiopacity (computed tomography) and density. In vitro cell viability was determined using an extract assay derived from each composition against the human hepatocellular carcinoma cell line, HepG2. Mathematical models based on a D-Optimal response surface methodology were used to determine the preferred radiopaque composite. The resulting radiopaque composite was validated and subsequently loaded with doxorubicin between 0 and 1.4% (wt% of polylactic-co-glycolic acid) to yield radiopaque composite drug-eluting beads. Thereafter, the radiopaque composite drug-eluting beads were subjected to an elution study (up to 168 h) to determine doxorubicin release profiles (UV-Vis spectroscopy) and in vitro cell viability. Radiopaque composites evaluated for screening purposes had densities between 1.28 and 1.67 g.cm(-3), radiopacity ranged between 211 and 1450HU and cell viabilities between 91 and 106% were observed. The optimized radiopaque composite comprised 23 wt% polylactic-co-glycolic acid and 60 wt% ORP5 with a corresponding density of 1.63 ± 0.001 g.cm(-3), radiopacity at 1930 ± 44HU and cell viability of 89 ± 7.6%. Radiopaque composite drug-eluting beads provided sustained doxorubicin release over 168 h. In conclusion, the mathematical models allowed for the identification and synthesis of a unique radiopaque composite. The optimized radiopaque composite had similar density and cell viability to commercially available embolic microspheres. It was possible to preload doxorubicin into radiopaque composite drug-eluting beads, such that sustained release was possible under simulated physiological conditions.

JOURNAL CLUB: CT dose optimization for whole-body PET/CT examinations.

OBJECTIVE. The objective of this study was to optimize CT protocols for whole-body PET/CT by reducing radiation dose while minimizing effects on image quality. MATERIALS AND METHODS. Before protocol optimization, a survey of 140 consecutive patients was conducted to establish the baseline dose from a whole-body PET/CT examination. Another sample of 100 patients was surveyed to evaluate the reduction of radiation dose after implementation of the new protocol. Effective dose from the CT component of the examination was estimated using dose-length product (DLP) values from reports generated by the scanner and anatomy-specific conversion factors. Twenty-six patients who underwent studies before and after the optimization were included in an analysis of image quality. All 26 patients had maintained the same weight between the examinations and were scanned in the same position using a similar technique except for the changes made for CT dose optimization. The studies were randomized and blinded for an experienced PET and CT reader who graded the imaging quality of anatomic structures. RESULTS. CT protocol optimization resulted in a 32% reduction of the mean CT radiation dose: The mean effective dose was reduced from 8.1 to 5.5 mSv. The blinded analysis of image quality showed no clinically significant degradation of the lower-dose studies. The only structures visualized statistically better on the higher-dose CT scans were the carotid arteries and the region of the posterior triangle. CONCLUSION. The results of this study showed that optimization of CT acquisition can effectively reduce radiation dose in a whole-body PET/CT examination without significantly sacrificing image quality.

Optical detection of gold nanoparticles in a prostate-shaped porcine phantom.

Gold nanoparticles can be used as molecular contrast agents binding specifically to cancer sites and thus delineating tumor regions. Imaging gold nanoparticles deeply embedded in tissues with optical techniques possesses significant challenges due to multiple scattering of optical photons that blur the obtained images. Both diagnostic and therapeutic applications can benefit from a minimally invasive technique that can identify, localize, and quantify the payloads of gold nanoparticles deeply embedded in biological tissues. An optical radiance technique is applied to map localized inclusions of gold nanorods in 650- to 900-nm spectral range in a porcine phantom that mimics prostate geometry. Optical radiance defines a variation in the angular density of photons impinging on a selected point in the tissue from various directions. The inclusions are formed by immersing a capillary filled with gold nanorods in the phantom at increasing distances from the detecting fiber. The technique allows the isolation of the spectroscopic signatures of the inclusions from the background and identification of inclusion locations in the angular domain. Detection of ∼4×1010 gold nanoparticles or 0.04 mg Au/mL (detector-inclusion separation 10 mm, source-detector separation 15 mm) in the porcine tissue is demonstrated. The encouraging results indicate a promising potential of radiance spectroscopy in early prostate cancer diagnostics with gold nanoparticles.

Local diagnostic reference levels for typical radiographic procedures.

PURPOSE: To establish local diagnostic reference levels (DRL) for typical radiographic examinations in a fully digital imaging institution. METHODS: The initial survey included 6 standard radiographic projections performed in 19 computed radiography (CR) and digital radiography (DR) rooms. Because of the expected difference in the performance, the local reference levels were analysed separately for those 2 modalities. Data of 226 average size adult patients were included in the analysis. Entrance surface dose (ESD) was calculated from the recorded radiographic techniques and tube radiation output measurements. After observing wide variations in the results of the patient survey, the examinations were repeated by using anthropomorphic phantoms. Initial efforts to understand the reasons for dose variations were focused on CR chest, abdomen, pelvis, and lumbar spine examinations. RESULTS: The average size patient doses for similar examinations were lower in the DR rooms than in the CR rooms by factors that ranged from 1.2 to 3, with the exception of the chest examination. Standardization of the CR exposure index value allowed us to decrease ESD by 21%-30%. Detector sensitivity had an insignificant effect (2%) on ESD; proper collimation lowered the dose by 17%. However, the major effect, up to 46% difference, was found because of antiscatter grids cutoff. CONCLUSION: Modality specific local diagnostic reference levels for standard examinations have been established in a large digital imaging department with hybrid modalities. Typically the local reference values were lower than those recommended in Safety Code 35, except for CR chests. Factors that affect the dose variations have been investigated and determined.

Implementation of automated tube current modulation in PET/CT: prospective selection of a noise index and retrospective patient analysis to ensure image quality.

UNLABELLED: Automated tube current modulation (ATCM) has been shown to be a useful tool for reducing CT dose. However, its implementation can be complicated, because the correlation between noise index (NI) settings and noise production can change as parameters are manipulated. The goal was to create a methodology to prospectively select ATCM parameters and retrospectively ensure consistent image quality. METHODS: An anthropomorphic phantom was scanned at various NIs to determine a baseline NI versus image noise. The noise was measured in SDs of the CT number reported in Hounsfield units. A physician then reviewed 45 studies performed with the same fixed-tube-current protocol to obtain a preferred noise level. The noise level was compared with our phantom baseline scans to find a suitable NI value. This value was implemented in clinical operation. Then, the next 50 patient examinations were retrospectively reviewed to ensure that image quality was maintained to our physician's cutoff noise levels. Radiation dose reductions through tube current reduction were measured for all CT slices of each patient study. RESULTS: In the phantom study, tube current modulation was observed at an NI of 15. The preferred noise level established in the physician's review correlated with an NI of 20. In our postimplementation analysis, we found that our noise level was 10.75 SDs in Hounsfield units. CT dose reductions of up to 52% were seen. CONCLUSION: We were able to prospectively select an NI for ATCM CT by correlating phantom scans to a physician's preferred noise level while maintaining consistent image quality.

Average CT in PET studies of colorectal cancer patients with metastasis in the liver and esophageal cancer patients.

Average CT (ACT) and PET have a similar temporal resolution and it has been shown to improve registration of the CT and PET data for PET/CT imaging of the thorax. The purpose of this study was to quantify the effect of ACT attenuation correction on PET for gross tumor volume (GTV) delineation with standardized uptake value (SUV) for liver and esophageal lesions. Our study included 48 colorectal cancer patients with metastasis in the liver and 52 esophageal cancer patients. These patients underwent a routine PET/CT scan followed by a cine CT scan of the thoracic region for ACT. Differences between the two PET data sets (PET HCT and PET ACT ) corrected with the helical CT (HCT) and ACT were quantified by analyzing image alignment, maximum SUV (SUV max ), and GTV. The 67% of the colorectal and 73% of the esophageal studies demonstrated misregistration between the PET HCT and HCT data. ACT was effective in removing misregistration artifacts in 65% of the misregisted colorectal and in 76% of the misregisted esophageal cancer patients. Misregistration between the CT and PET data affected GTVs due to the change in SUV max with ACT. A change of SUV max greater than 20% between PET HCT and PET ACT was found in 15% of the colorectal and 17% of the esophageal cases. Our results demonstrated a more pronounced effect of misregistration for the smaller lesions (< 5 cm 3 ) near the diaphragm (< 5 cm). ACT was effective in improving registration between the CT and PET data in PET/CT for the colorectal and esophageal cancer patients.